161 related articles for article (PubMed ID: 38332165)
1. Analysis of clinicopathologic and imaging features of dual-phenotype hepatocellular carcinoma.
Huang K; He Y; Liang T; Mo S; Liao Y; Gao Q; Liao X; Han C; Zhu G; Peng T
Sci Rep; 2024 Feb; 14(1):3314. PubMed ID: 38332165
[TBL] [Abstract][Full Text] [Related]
2. Hepatocellular carcinoma expressing cholangiocyte phenotype is a novel subtype with highly aggressive behavior.
Lu XY; Xi T; Lau WY; Dong H; Zhu Z; Shen F; Wu MC; Cong WM
Ann Surg Oncol; 2011 Aug; 18(8):2210-7. PubMed ID: 21308485
[TBL] [Abstract][Full Text] [Related]
3. CK19 Predicts Recurrence and Prognosis of HBV Positive HCC.
Shuyao W; Mingyang B; Feifei M; Xiaoqin H
J Gastrointest Surg; 2022 Feb; 26(2):341-351. PubMed ID: 34506016
[TBL] [Abstract][Full Text] [Related]
4. [CK19 can be used to predict the early recurrence and prognosis of HBV-related hepatocellular carcinoma patients with low AFP serum concentration after R0 radical hepatectomy].
Wang ZS; Wu LQ; Yi X; Geng C; Li YJ; Yao RY; Hu WY; Han B
Zhonghua Zhong Liu Za Zhi; 2012 Oct; 34(10):753-8. PubMed ID: 23291069
[TBL] [Abstract][Full Text] [Related]
5. Radiomics for diagnosis of dual-phenotype hepatocellular carcinoma using Gd-EOB-DTPA-enhanced MRI and patient prognosis.
Huang X; Long L; Wei J; Li Y; Xia Y; Zuo P; Chai X
J Cancer Res Clin Oncol; 2019 Dec; 145(12):2995-3003. PubMed ID: 31664520
[TBL] [Abstract][Full Text] [Related]
6. A radiomics model based on magnetic resonance imaging to predict cytokeratin 7/19 expression and liver fluke infection of hepatocellular carcinoma.
Liu JQ; Wang J; Huang XL; Liang TY; Zhou X; Mo ST; Xie HX; Yang KJ; Zhu GZ; Su H; Liao XW; Long LL; Peng T
Sci Rep; 2023 Oct; 13(1):17553. PubMed ID: 37845287
[TBL] [Abstract][Full Text] [Related]
7. Cytokeratin 19 expression in hepatocellular carcinoma predicts early postoperative recurrence.
Uenishi T; Kubo S; Yamamoto T; Shuto T; Ogawa M; Tanaka H; Tanaka S; Kaneda K; Hirohashi K
Cancer Sci; 2003 Oct; 94(10):851-7. PubMed ID: 14556657
[TBL] [Abstract][Full Text] [Related]
8. The clinicopathological and prognostic relevance of cytokeratin 7 and 19 expression in hepatocellular carcinoma. A possible progenitor cell origin.
Durnez A; Verslype C; Nevens F; Fevery J; Aerts R; Pirenne J; Lesaffre E; Libbrecht L; Desmet V; Roskams T
Histopathology; 2006 Aug; 49(2):138-51. PubMed ID: 16879391
[TBL] [Abstract][Full Text] [Related]
9. [Diagnostic value of absent ductular reaction at hepatocellular-stromal boundaries in early stage hepatocellular carcinoma].
Zhang Q; Ma Z; Xin Q; Liu GQ; Liu BB; Gao YT; Zhang CS; Du Z
Zhonghua Gan Zang Bing Za Zhi; 2013 Dec; 21(12):924-8. PubMed ID: 24636295
[TBL] [Abstract][Full Text] [Related]
10. Imaging Features of Gadoxetic Acid-enhanced and Diffusion-weighted MR Imaging for Identifying Cytokeratin 19-positive Hepatocellular Carcinoma: A Retrospective Observational Study.
Choi SY; Kim SH; Park CK; Min JH; Lee JE; Choi YH; Lee BR
Radiology; 2018 Mar; 286(3):897-908. PubMed ID: 29166246
[TBL] [Abstract][Full Text] [Related]
11. Immunohistochemical markers for hepatocellular carcinoma prognosis after liver resection and liver transplantation.
Lee SH; Lee JS; Na GH; You YK; Kim DG
Clin Transplant; 2017 Jan; 31(1):. PubMed ID: 27653235
[TBL] [Abstract][Full Text] [Related]
12. Gadoxetic Acid-Enhanced MRI-Based Radiomics Signature: A Potential Imaging Biomarker for Identifying Cytokeratin 19-Positive Hepatocellular Carcinoma.
Hu X; Wang Q; Huang G; He X; Sparrelid E; Brismar TB; Fan Y
Comput Math Methods Med; 2023; 2023():5424204. PubMed ID: 36814805
[TBL] [Abstract][Full Text] [Related]
13. [Correlation analysis of Ki67, Ck19 with clinicopathological features and apparent diffusion coefficient value of hepatocellular carcinoma].
Han S; Meng F; Zhang HK; Li HL; Qu JR
Zhonghua Yi Xue Za Zhi; 2021 Mar; 101(11):798-802. PubMed ID: 33765721
[No Abstract] [Full Text] [Related]
14. Microvascular invasion is associated with poor survival in patients with dual-phenotype hepatocellular carcinoma.
Ouyang X; Yan Y; Zhang S; Li M; Li M; Liu Q
Am J Clin Pathol; 2024 Mar; 161(3):245-255. PubMed ID: 37947176
[TBL] [Abstract][Full Text] [Related]
15. Diagnostic Value of MRI Features in Dual-phenotype Hepatocellular Carcinoma: A Preliminary Study.
Gu HX; Huang XS; Xu JX; Zhu P; Xu JF; Fan SF
J Digit Imaging; 2023 Dec; 36(6):2554-2566. PubMed ID: 37578576
[TBL] [Abstract][Full Text] [Related]
16. Comparison of Liver Transplantation and Liver Resection for Hepatocellular Carcinoma Patients with Portal Vein Tumor Thrombus Type I and Type II.
Lv JY; Zhang NN; Du YW; Wu Y; Song TQ; Zhang YM; Qu Y; Liu YX; Gu J; Wang ZY; Qiu YB; Yang B; Tian DZ; Guo QJ; Zhang L; Sun JS; Xie Y; Wang ZL; Sun X; Jiang WT; Lu W
Yonsei Med J; 2021 Jan; 62(1):29-40. PubMed ID: 33381932
[TBL] [Abstract][Full Text] [Related]
17. Prognostic implications of tumor vascularity and its relationship to cytokeratin 19 expression in patients with hepatocellular carcinoma.
Chung GE; Lee JH; Yoon JH; Myung SJ; Lee K; Jang JJ; Lee JM; Kim SH; Suh KS; Kim YJ; Lee HS
Abdom Imaging; 2012 Jun; 37(3):439-46. PubMed ID: 21584634
[TBL] [Abstract][Full Text] [Related]
18. Prognosis of hepatocellular carcinoma expressing cytokeratin 19: comparison with other liver cancers.
Lee JI; Lee JW; Kim JM; Kim JK; Chung HJ; Kim YS
World J Gastroenterol; 2012 Sep; 18(34):4751-7. PubMed ID: 23002345
[TBL] [Abstract][Full Text] [Related]
19. Magnetic resonance texture analysis for the identification of cytokeratin 19-positive hepatocellular carcinoma.
Wang HQ; Yang C; Zeng MS; Rao SX; Ji Y; Weng X; Wang JY; Sheng RF
Eur J Radiol; 2019 Aug; 117():164-170. PubMed ID: 31307643
[TBL] [Abstract][Full Text] [Related]
20. Cytokeratin 10 and cytokeratin 19: predictive markers for poor prognosis in hepatocellular carcinoma patients after curative resection.
Yang XR; Xu Y; Shi GM; Fan J; Zhou J; Ji Y; Sun HC; Qiu SJ; Yu B; Gao Q; He YZ; Qin WZ; Chen RX; Yang GH; Wu B; Lu Q; Wu ZQ; Tang ZY
Clin Cancer Res; 2008 Jun; 14(12):3850-9. PubMed ID: 18559605
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
